You are here

  • Home
  • Archive
  • Volume 19, Issue 2
  • Systematic review suggests TNF-α inhibitors may be rational options for pregnant patients with inflammatory bowel disease

Article Text

Article menu
Download PDFPDF
Harms
Systematic review
Systematic review suggests TNF-α inhibitors may be rational options for pregnant patients with inflammatory bowel disease

https://doi.org/10.1136/eb-2013-101536

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Competing interests BGL reports personal fees from Prometheus Labs, personal fees from Santarus Inc, personal fees from UCB Pharma, personal fees from Warner Chilcott and personal fees from Salix, outside the submitted work.